Copper induces microglia-mediated neuroinflammation through ROS/NF-κB pathway and mitophagy disorder

Qian Zhou1, Ying Zhang1, Lu Lu1

  • 1Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.

Insights

Copper exposure triggers microglial activation and inflammation, leading to dopaminergic neuron death. This process involves reactive oxygen species (ROS) and mitophagy dysfunction, contributing to Parkinson disease pathogenesis.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Epidemiological studies link copper exposure to increased Parkinson disease (PD) risk.
  • Microglia-mediated neuroinflammation is a key factor in PD pathogenesis.

Purpose of the Study:

  • To investigate microglial activation and neuroinflammation in copper neurotoxicity.
  • To elucidate the mechanism of copper-induced microglial activation.

Main Methods:

  • Examined inflammatory changes, microglial activation, dopaminergic neuron loss, and alpha-synuclein aggregation in mouse brain tissue.
  • Assessed copper-induced inflammatory activation, reactive oxygen species (ROS) production, and NF-κB pathway activation in BV2 cells.
  • Analyzed mitochondrial function, mitophagy markers (Parkin, PINK1, P62, LC3B), and pyroptosis-related proteins (NLRP3/caspase1/GSDMD axis).

Main Results:

  • Copper exposure activated microglia and increased ROS levels, activating the NF-κB pathway in BV2 cells.
  • Sustained copper accumulation impaired mitochondrial function, disrupted mitophagy, and upregulated the NLRP3/caspase1/GSDMD axis.
  • Redox agents, NF-κB inhibitors, and mitophagy inducers mitigated inflammatory factor release.

Conclusions:

  • Copper exposure activates microglia, leading to neuroinflammation and dopaminergic neuron pyroptosis.
  • The mechanism involves early ROS/NF-κB pathway activation and subsequent mitophagy disorder.
  • These findings highlight copper's role in PD pathogenesis via microglial-mediated neuroinflammation.